Cerebral malaria is one of a number of clinical syndromes associated with infection by human malaria parasites of the genus Plasmodium ... of the host and virulence characteristics of the ...

Scientists are exploring the key proteins and metabolic pathways in Plasmodium falciparum to develop new drugs to prevent malaria. Pink block arrows indicate the steps inhibited by antimalarial ...

Two studies show that Plasmodium—the genus of protozoans that cause malaria—have an internal sense of time that synchronizes with their host’s circadian rhythms and allows the parasites to ...

The journey to eliminate malaria is complex, hindered by the parasite's adaptability and challenges in vaccine development.

A new, comprehensive map of all the genes essential for blood infections in Plasmodium knowlesi (P. knowlesi), a parasite ...

A new, comprehensive map of all the genes essential for blood infections in Plasmodium knowlesi (P. knowlesi), a parasite that causes malaria in humans, has been generated. The map contains the ...

Plasmodium falciparum. There are obvious questions that come to mind, including the simplest, why did it take so long for a vaccine to be developed for a disease that kills more than 250,000 ...

The team developed a novel vaccine that contains an mRNA sequence for ribosomal protein L6 (RPL6), a highly conserved Plasmodium protein. This protein is expressed consistently while the parasites are ...

Comprehensive genetic mapping of Plasmodium knowlesi, a zoonotic parasite that causes malaria, has revealed the genes required for malaria infection of the blood, and those driving drug resistance.